Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown.

The aim of the study was to determine the differential expression of nitric oxide (NO) synthase (NOS) isoforms and the pathophysiologic relevance of inducible NOS (iNOS) in experimental pneumococcal meningitis. By use of reverse transcription-polymerase chain reaction analysis, immunohistochemistry, and Western blotting, increased brain mRNA and increased protein levels of endothelial NOS (eNOS) and iNOS were detected 24 h after intracisternal pneumococcal inoculation. In iNOS-deficient mice, disruption of the blood-brain barrier (BBB) was significantly reduced, compared with that in wild-type mice. This beneficial effect of iNOS deficiency was associated with a lack of nitrotyrosine immunoreactivity. Furthermore, brain protein levels of interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha and brain mRNA levels of macrophage inflammatory protein (MIP)-1alpha and MIP-2 were significantly reduced in infected animals lacking iNOS. These findings suggest that (1) not only iNOS but also eNOS is up-regulated in the acute phase of experimental bacterial meningitis, and (2) iNOS-derived NO contributes to peroxynitrite formation and BBB breaching in this disease.

[1]  M. Dikshit,et al.  Modulation of polymorphonuclear leukocytes function by nitric oxide. , 2000, Thrombosis research.

[2]  W. Mayhan.  Nitric oxide donor-induced increase in permeability of the blood–brain barrier , 2000, Brain Research.

[3]  M. Takiguchi,et al.  Induction of Endothelial Nitric-oxide Synthase in Rat Brain Astrocytes by Systemic Lipopolysaccharide Treatment* , 2000, The Journal of Biological Chemistry.

[4]  H. Koprowski,et al.  Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood–CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  C. Bogdan,et al.  Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. , 2000, Current opinion in immunology.

[6]  P. Huang.  Lessons learned from nitric oxide synthase knockout animals. , 2000, Seminars in perinatology.

[7]  C. Bogdan,et al.  The role of nitric oxide in innate immunity , 2000, Immunological reviews.

[8]  T. Akaike,et al.  Direct Evidence of in Vivo Nitric Oxide Production and Inducible Nitric Oxide Synthase mRNA Expression in the Brain of Living Rat during Experimental Meningitis , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  H. Pfister,et al.  Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. , 1999, The Journal of infectious diseases.

[10]  S. Leib,et al.  Pathogenesis of bacterial meningitis. , 1999, Infectious disease clinics of North America.

[11]  Steven P Jones,et al.  Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. , 1999, American journal of physiology. Heart and circulatory physiology.

[12]  O. Griffith,et al.  Mammalian nitric oxide synthases. , 1999, Advances in enzymology and related areas of molecular biology.

[13]  J. Licinio,et al.  Brain iNOS: current understanding and clinical implications. , 1999, Molecular medicine today.

[14]  M. Perretti,et al.  Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan‐induced inflammation , 1998, Immunology.

[15]  U. Förstermann,et al.  Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III) , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  C. Bogdan.  The Multiplex Function of Nitric Oxide in (Auto)immunity , 1998, The Journal of experimental medicine.

[17]  K. Spanaus,et al.  Chemokines and chemotaxis of leukocytes in infectious meningitis , 1998, Journal of Neuroimmunology.

[18]  S. Black,et al.  Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. , 1998, The Journal of infectious diseases.

[19]  C. Nathan,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Inducible Nitric Oxide Synthase : What Difference Does It Make ? , 2013 .

[20]  A. Schuchat,et al.  Bacterial Meningitis in the United States in 1995 , 1997 .

[21]  P. Kubes,et al.  Inducible nitric oxide synthase‐deficient mice have enhanced leukocyte–endothelium interactions in endotoxemia , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  D. Payan,et al.  The control of microvascular permeability and blood pressure by neutral endopeptidase , 1997, Nature Medicine.

[23]  H. Pfister,et al.  Brain injury in bacterial meningitis: therapeutic implications , 1997, Current opinion in neurology.

[24]  A. Sher,et al.  Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii , 1997, The Journal of experimental medicine.

[25]  H. Pfister,et al.  Protective effect of the antioxidant N-acetyl-l-cysteine in pneumococcal meningitis in the rat , 1997, Neuroscience Letters.

[26]  W. Mayhan.  Role of nitric oxide in histamine-induced increases in permeability of the blood–brain barrier , 1996, Brain Research.

[27]  K. Frei,et al.  Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. , 1996, Journal of immunology.

[28]  A. Villringer,et al.  Role of Nitric Oxide Synthase Inhibition in Leukocyte-Endothelium Interaction in the Rat Pial Microvasculature , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[30]  K. Black,et al.  Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. , 1996, Cancer research.

[31]  W. Hop,et al.  The role of nitric oxide in bacterial meningitis in children. , 1996, The Journal of infectious diseases.

[32]  K. Boje.  Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis , 1996, Brain Research.

[33]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[34]  W. Wood,et al.  Chemokine binding and activities mediated by the mouse IL-8 receptor. , 1995, Journal of immunology.

[35]  C. Nathan,et al.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.

[36]  K. Frei,et al.  Experimental pneumococcal meningitis: Cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide , 1995, Annals of neurology.

[37]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[38]  H. Pfister,et al.  Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis? , 1994, Neurological research.

[39]  K. Einhäupl,et al.  Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. , 1993, Archives of neurology.

[40]  V. Caviness,et al.  Acute bacterial meningitis in adults. A review of 493 episodes. , 1993, The New England journal of medicine.

[41]  C. Nathan,et al.  Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Cerami,et al.  The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis , 1990, The Journal of experimental medicine.

[43]  E. Tuomanen,et al.  Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes , 1989, The Journal of experimental medicine.